Holen Sie sich die Stockscreener-App
11.26
2.74%
0.30
Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 1.314 | - | - |
| Operating Expenses |
28.19%
11.58
|
16.12 | 7.351 | 8.629 | 12.82 |
| Operating Income/Loss |
28.19%
-11.58
|
-16.12 | -7.351 | -8.629 | -12.82 |
| Income/Loss From Continuing Operations Before Tax |
28.15%
-11.25
|
-15.66 | -7.155 | -8.392 | -12.51 |
| Income/Loss From Continuing Operations After Tax |
28.15%
-11.25
|
-15.66 | -7.155 | -8.392 | -12.51 |
Net Income/Loss
|
28.15%
-11.25
|
-15.66 | -7.155 | -8.392 | -12.51 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
29.93%
-0.96
|
-1.37 | 3.18 | -4.54 | -0.27 |
| Diluted Earnings Per Share |
29.93%
-0.96
|
-1.37 | 3.18 | -4.54 | -0.27 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):